Raynaud's phenomenon in children;Phénomène de Raynaud chez l'enfant

Archives de Pediatrie

Volumn 11, Issue 1, 2004, Pages 74-77

  Quartier, P ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Child; Connective tissue disease; Raynaud's phenomenon

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CARBACYCLIN; ILOPROST;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CHILD; CLINICAL FEATURE; COLD EXPOSURE; CONNECTIVE TISSUE DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE COURSE; EPIDEMIOLOGICAL DATA; ERYTHROMELALGIA; HUMAN; PATHOPHYSIOLOGY; RAYNAUD PHENOMENON; SEX DIFFERENCE; THERMOGRAPHY;

EID: 0346368328     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2003.09.030     Document Type: Article

References (22)

1. Olsen N, Nielsen SL. Prevalence of primary Raynaud phenomena in young females. Scand J Clin Lab Invest 1978;38(8):761-4.
2. Maricq HR, Weinrich MC, Keil JE, LeRoy EC. Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire. J Chronic Dis 1986;39(6):423-7.
3. Keil JE, Maricq HR, Weinrich MC, McGregor AR, Diat F. Demographic, social and clinical correlates of Raynaud phenomenon. Int J Epidemiol 1991;20(1):221-4.
4. Valter I, Maricq HR. Prevalence of Raynaud phenomenon in Tartu and Tartumaa, southern Estonia. Scand J Rheumatol 1997;26(2):117-24.
5. Duffy CM, Laxer RM, Lee P, Ramsay C, Fritzler M, Silverman ED. Raynaud syndrome in childhood. J Pediatr 1989;114(1):73-8.
6. Gonzalez Pascual E, Esquinas Rychen G, Ruiz Espana A, Ros Viladoms JB, Juanola Roura X. Raynaud phenomenon in childhood: review and progress control in eight cases. An Esp Pediatr 1998;48 (6):603-7.
7. Kone-Paut I, Olivar E, Elbhar C, Garnier JM, Berbis P. Syndrome de Raynaud de l'enfant. Etude de 23 cas. Arch Pediatr 2002;9(4):365-70.
8. O'Keeffe ST, Tsapatsaris NP, Beetham Jr. WP. Increased prevalence of migraine and chest pain in patients with primary Raynaud disease. Ann Intern Med 1992;116(12 Pt 1):985-9.
9. Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998;158(6):595-600.
10. Schapira D, Nahir AM, Hadad N. Interferon-induced Raynaud's syndrome. Semin Arthritis Rheum 2002;32(3):157-62.
11. Gasbarrini A, Serricchio M, Tondi P, Gasbarrini G, Pola P. Association of Helicobacter pylori infection with primary Raynaud phenomenon. Lancet 1996;348(9032):966-7.
12. Tan FK, Arnett FC. Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon. Curr Opin Rheumatol 2000;12 (6):511-9.
13. Caspary L, Schmees C, Schoetensack I, et al. Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosus. J Rheumatol 1991;18(4): 559-66.
14. Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon. Results from a randomized clinical trial with 1-year follow-up. Arch Intern Med 2000;160(8):1101-8.
15. Wigley FM, Wise RA, Seibold JR, et al. Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 1994;120(3):199-206.
16. Binaghi F, Cannas F, Mathieu A, Pitzus F. Correlations among capillaroscopic abnormalities, digital flow and immunologic findings in patients with isolated Raynaud's phenomenon. Can laser Doppler flowmetry help identify a secondary Raynaud phenomenon? Int Angiol 1992;11 (3):186-94.
17. Yokota S, Kuriyama T, Takahashi Y, et al. Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease. Ryumachi 1994;34(6):955-60.
18. Maricq HR, Jennings JR, Valter I, et al. Evaluation of treatment efficacy of Raynaud phenomenon by digital blood pressure response to cooling. Raynaud's Treatment Study Investigators. Vasc Med 2000;5 (3):135-40.
19. Merla A, Romani GL, Di Luzio S, et al. Raynaud's phenomenon: Infrared functional imaging applied to diagnosis and drug effects. Int J Immunopathol Pharmacol 2002;15(1):41-52.
20. Controlled multicenter double-blind trial of nicardipine in the treatment of primary Raynaud phenomenon. Am Heart J 1991;122 (1 Pt 2):352-5 French Cooperative Multicenter Group for Raynaud Phenomenon, Paris, France.
21. Varela-Aguilar JM, Sanchez-Roman J, Talegon Melendez A, Castillo Palma MJ. Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex. Rev Clin Esp 1997;197(2):77-83.
22. Seemann J, Scholz J, Sielwicz M. Remission of secondary Raynaud phenomenon using intra-arterial prostaglandin EI infusion. A case report. Int Orthop 1994;18(6):372-4.